# US 2024/0180556 A1 · Devices, systems, and methods for treating pulmonary disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0180556 A1
- Document ID: US20240180556A1
- Status: Published application
- Kind: A1
- Application number: 18/553,788
- Filed: 2022-04-08
- Published: 2024-06-06
- Earliest claimed: 2021-04-08
- Assignees: Apreo Health, Inc.
- Applicants: Apreo Health, Inc.
- Inventors: James I. Fann; Steven W. Kim; Hanson S. Gifford, III; Douglas S. Sutton; Martin L. Mayse; Karun D. Naga
- Web page: https://patentgrep.com/patent/US20240180556A1

## CPC

- A61B 17/12009: {Implements for ligaturing other than by clamps or clips, e.g. using a loop with a slip knot}
- A61B 17/12013: {for use in minimally invasive surgery, e.g. endoscopic surgery}
- A61B 5/026: Measuring blood flow {(A61B3/1233, A61B3/1241 take precedence)}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61B 5/6867: {specially adapted to be attached or implanted in a specific body part (A61B5/6847 takes precedence)}
- A61B 18/00: Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body (eye surgery A61F9/007; ear surgery A61F11/00)
- A61B 2017/00004: {(bio)absorbable, (bio)resorbable or resorptive}
- A61B 2017/00022: {Sensing or detecting at the treatment site}
- A61B 2017/00522: {Sprayers}
- A61B 2017/00535: {pneumatically or hydraulically operated (A61B2017/22051, A61B2090/401 take precedence)}
- A61B 2017/00539: {hydraulically}
- A61B 2017/00809: {Lung operations}
- A61B 2017/00867: {shape memory effect}
- A61B 2017/00893: {pharmaceutically effective}
- A61B 2017/12018: {Elastic band ligators}
- A61B 2018/00541: {Lung or bronchi}
- A61B 2018/00619: {Welding}
- A61F 2/0063: {Implantable repair or support meshes, e.g. hernia meshes}
- A61F 2002/0072: {Delivery tools therefor}
- A61F 2220/0083: using hook and loop-type fasteners
- A61F 2230/0067: conical
- A61F 2230/0069: cylindrical
- A61F 2230/0086: Pyramidal, tetrahedral, or wedge-shaped
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Devices, systems, and methods for treating pulmonary disease are disclosed herein. According to some embodiments, the present technology includes identifying diseased tissue on a lobe of the patient's lung, collapsing the lobe, and percutaneously inserting a device into the patient and a therapeutic element carried by the device. The present technology further includes thoracoscopically delivering the therapeutic element into the patient's chest cavity, administering the therapeutic element on and around at least the diseased tissue, and applying an atraumatic compressive load to and/or restricting expansion of at least a portion of the diseased tissue.

## Claims

### Claim 1

A system for treating a patient having emphysema via thoracoscopic lung volume reduction, the system comprising:
a therapeutic element having a low-profile configuration for thoracoscopic delivery to the patient's chest cavity and an expanded configuration in which the therapeutic element is configured to be disposed on an outer surface of a diseased portion of a patient's lung; and
an applicator configured to manipulate the therapeutic element within the chest cavity to place the therapeutic element in contact with the diseased portion of the patient's lung when the lung is collapsed,
wherein the therapeutic element is configured to apply a compressive load to and/or restrict expansion of the diseased portion of the patient's lung, and
wherein the therapeutic element is configured to, upon reinflation of the patient's lung, restrict airflow to the diseased portion of the patient's lung, thereby achieving a lung volume reduction, and
wherein interaction between the patient's lung and the therapeutic element produces a contact force and the therapeutic element is configured to distribute the contact force so as to maintain perfusion to the diseased portion of the patient's lung and/or minimize tension in the at least a diseased portion of the patient's lung.

### Claim 2 (depends on 1)

The system of claim 1, wherein the therapeutic element comprises a flexible film.

### Claim 3 (depends on 1)

The system of claim 1, wherein the applicator comprises a plurality of arms and is configured to transform the therapeutic element from the low-profile configuration to the expanded configuration while the therapeutic element is disposed within the chest cavity.

### Claim 4 (depends on 1)

The system of claim 1, wherein the therapeutic element comprises a flexible film, and wherein, when the film is in the low-profile configuration, the film is rolled up.

### Claim 5 (depends on 4)

The system of claim 4, wherein the applicator is configured to transform the film from the low-profile configuration to the expanded configuration by unrolling the film.

### Claim 6 (depends on 4)

The system of claim 4, wherein the applicator comprises a first arm and a second arm, and wherein the first arm is configured to unroll the film from and the second arm is configured to stabilize the film.

### Claim 7 (depends on 1)

The system of claim 1, wherein the therapeutic element comprises a tubular sleeve.

### Claim 8 (depends on 1)

The system of claim 1, wherein the therapeutic element is configured to be wrapped around the lung at least one once.

### Claim 9 (depends on 1)

The system of claim 1, wherein the therapeutic element is configured to adhere to itself.

### Claim 10 (depends on 1)

The system of claim 1, wherein the therapeutic element is configured to be wrapped around the lung at least once and secured via a fastener.

### Claim 11 (depends on 10)

The system of claim 10, wherein the therapeutic element is a film and the fastener comprises a thicker portion of the film that generates friction with the lung tissue having a magnitude that is greater than a magnitude of friction generated between the rest of the film and the lung tissue.

### Claim 12 (depends on 11)

The system of claim 11, wherein the therapeutic element is configured to be positioned on a lobe of the lung such that the fastener is aligned with a lower edge of the lobe.

### Claim 13 (depends on 1)

The system of claim 1, further comprising a fastener, and wherein the fastener is configured to secure the therapeutic element to itself such that the lung tissue is compressively engaged and/or captured within the therapeutic element without the fastener directly engaging the lung tissue, and wherein the fastener comprises at least one of: an adhesive, a mechanical fastener, and/or a weld in situ.

### Claim 14 (depends on 1)

The system of claim 1, wherein, when the therapeutic element is positioned over the diseased portion of the lung, the therapeutic element has an end portion that is open and exposing the diseased portion to the pleural cavity, and wherein the system further includes a band configured to be positioned around the open end portion to close the end portion, thereby limiting or preventing the passage of air between the pleural cavity and the diseased portion and limiting or preventing herniation of the diseased portion.

### Claim 15 (depends on 1)

The system of claim 1, wherein the therapeutic element is configured to be substantially impermeable to air to seal the lung tissue and prevent leaks.

### Claim 16 (depends on 1)

The system of claim 1, wherein the therapeutic element comprises a film and a substance comprising a liquid or gel.

### Claim 17 (depends on 16)

The system of claim 16, wherein the substance comprises a biological or polymeric resin and/or glue.

### Claim 18 (depends on 16)

The system of claim 16, wherein the substance is configured to be applied to fill interstitial voids between the film and healthy and/or diseased lung tissue to improve attachment and/or sealing between the therapeutic element and the lung tissue.

### Claim 19 (depends on 1)

The system of claim 1, wherein the liquid or gel substance is configured to be applied outside the film (i.e., on the other side of the film from the tissue-facing side), and wherein the liquid or gel substance is configured to cure and set the film in a substantially rigid form to restrict expansion of the at least a diseased portion of the patient's lung.

### Claim 20 (depends on 1)

The system of claim 1, wherein the therapeutic element is configured to secure the at least a diseased portion of the patient's lung in a substantially flat configuration (i.e., length and/or width are substantially greater than the thickness), and wherein the substantially flat configuration minimizes the contact force and attenuates tension in the lung tissue.

### Claim 21 (depends on 1)

The system of claim 1, wherein the therapeutic element comprises a polymer coating configured to adhere to the diseased portion of the patient's lung, and wherein the polymer coating is configured to be sprayed onto the patient's lung when the patient's lung is in a collapsed state.

### Claim 22 (depends on 21)

The system of claim 21, wherein the therapeutic element further comprises a biocompatible film, and wherein the film is configured to be applied to and/or wrapped around the polymer coating.

### Claim 23 (depends on 22)

The system of claim 22, wherein the film is configured to be a buttress for the polymer coating to enhance fixation and/or sealing of the therapeutic element.

### Claim 24 (depends on 1)

The system of claim 1, wherein the therapeutic element includes a therapeutic agent and is configured to deliver the therapeutic agent to the lung tissue while the therapeutic element is secured to the lung tissue.

### Claim 25 (depends on 24)

The system of claim 24, wherein the therapeutic agent is at least one of any anti-inflammatory, an antibiotic, and/or an anesthetic.

### Claim 26 (depends on 24)

The system of claim 24, wherein the therapeutic element comprises a polymeric coating or film that is loaded with the therapeutic agent.

### Claim 27 (depends on 1)

The system of claim 1, wherein the therapeutic element comprises a biocompatible material, wherein the biocompatible material: (a) is either non-degradable, partially-degradable or fully-degradable material, (b) comprises a polymeric or biological material, and/or (c) comprises at least one of silicone, polyurethane, PTE, PTFE, polyester, nylon, PLGA, PLA, PCL (polycaprolactone), PLCL and combinations thereof.

### Claim 28 (depends on 1)

The system of claim 1, wherein the therapeutic element is configured for thoracoscopic delivery through at least one port in the wall of the chest of the patent.

### Claim 29 (depends on 1)

The system of a claim 1, wherein the system includes a thoracoscope camera.

### Claim 30 (depends on 1)

The system of claim 1, wherein the therapeutic element is configured for thoracoscopic delivery via a single port.

### Claim 31 (depends on 1)

The system of claim 1, wherein the therapeutic element is configured for thoracoscopic delivery via a multiple ports.

### Claim 32 (depends on 1)

The system of claim 1, wherein the therapeutic element comprises a mesh.

### Claim 33 (depends on 32)

The system of claim 32, wherein the therapeutic element further comprises a polymer film and/or adhesive configured to secure the mesh to the diseased portion of the lung.

### Claim 34 (depends on 1)

The system of claim 1, wherein the therapeutic element comprises a structure configured to be disposed on and around the diseased portion of the patient's lung, wherein the structure includes a channel configured to receive a fluid therethrough.

### Claim 35 (depends on 34)

The system of claim 34, wherein a size and/or shape of the structure can be adjusted by controlled delivery of the fluid to and withdrawal of the fluid from the structure, thereby enabling in-situ customization of the therapeutic element.

### Claim 36 (depends on 34)

The system of claim 34, wherein upon initial placement of the therapeutic element against the lung tissue, the channel is configured to receive a volume the fluid to confirm apposition of the therapeutic element and the lung tissue and/or a contact force between the therapeutic element and the lung tissue, and, after the fluid is evacuated from the channel, the channel is configured to receive a volume of a substance equal to the volume of fluid, wherein the substance is configured to solidify in-situ and take a permanent shape consistent with the confirmed apposition and/or contact force.

### Claim 37 (depends on 34)

The system of claim 34, wherein the structure is configured to assume a triangular two-dimensional (2D) shape and/or a conical and/or pyramidal three-dimensional (3D) shape when the fluid is delivered to the channel to approximate the native geometry of the portion of the lung contained by the therapeutic element, and wherein the 2D and/or 3D shape enables the therapeutic element to prevent or limit twisting of the contained portion of the lung upon re-inflation of the remainder of the lung, and wherein the therapeutic element is configured to limit or prevent constriction of the vasculature perfusing the contained portion of the lung.

### Claim 38 (depends on 34)

The system of claim 34, further comprising a substance configured to be delivered into the channel and solidify within the channel to rigidize the structure in a desired shape.

### Claim 39 (depends on 1)

The system of claim 1, further comprising a sensor, incorporated into or independent of the therapeutic element, wherein the sensor is configured to monitor perfusion to the portion of the lung contained by the therapeutic element to reduce a risk of ischemia and necrosis of the contained portion of the lung.

### Claim 40 (depends on 1)

The system of claim 1, further comprising an imaging device for monitoring the patient following placement of the therapeutic element.

### Claim 41 (depends on 40)

The system of claim 40, wherein the imaging device is configured to obtain image data via computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), ultrasound, X-ray, or combinations thereof.

### Claim 42 (depends on 41)

The system of claim 41, wherein the therapeutic element includes an enhancing agent for enhancing visualization of the therapeutic element when imaged by the imaging device.

### Claim 43 (depends on 1)

The system of claim 1, wherein the therapeutic element is configured to have a triangular two-dimensional (2D) shape and/or a conical and/or pyramidal three-dimensional (3D) shape when in an expanded configuration and restricting expansion of the lung.

### Claim 44

A device for treating a patient having emphysema via thoracoscopic lung volume reduction, the device comprising:
a therapeutic element having a low-profile configuration for thoracoscopic delivery to the patient's chest cavity and an expanded configuration in which the therapeutic element is configured to be disposed on an outer surface of a diseased portion of a patient's lung; and
wherein the therapeutic element is configured to apply a compressive load to and/or restrict expansion of the diseased portion of the patient's lung, and
wherein the therapeutic element is configured to, upon reinflation of the patient's lung, restrict airflow to the diseased portion of the patient's lung, thereby achieving a lung volume reduction, and
wherein interaction between the patient's lung and the therapeutic element produces a contact force and the therapeutic element is configured to distribute the contact force so as to maintain perfusion to the diseased portion of the patient's lung and/or minimize tension in the at least a diseased portion of the patient's lung.

### Claim 45 (depends on 44)

The device of claim 44, wherein the therapeutic element comprises a cover.

### Claim 46 (depends on 44)

The device of claim 44, wherein the therapeutic element comprises a fastener.
